uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy
uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, InnoVec Biotherapeutics, has received FDA clearance for its Investigational New...